Thrombocytopenia caused by albendazole in a patient with Sjögren's syndrome: A case report

Sjögren's syndrome (SS) is an autoimmune disease characterised by a chronic inflammatory response mainly localised to the lachrymal and salivary glands. Haematological abnormalities are common, although they rarely have clinical significance. Here, we report a patient with SS and thrombocytopen...

Full description

Saved in:
Bibliographic Details
Published in:European journal of rheumatology 2014-03, Vol.1 (1), p.44-45
Main Authors: Açıkgöz, Pınar, Türkbeyler, İbrahim Halil, Pehlivan, Yavuz
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sjögren's syndrome (SS) is an autoimmune disease characterised by a chronic inflammatory response mainly localised to the lachrymal and salivary glands. Haematological abnormalities are common, although they rarely have clinical significance. Here, we report a patient with SS and thrombocytopenia caused by albendazole. Haematological abnormalities such as thrombocytopenia are seen in approximately 5-15% of SS patients; however, this disease is usually asymptomatic and can often be recovered to normal levels with corticosteroids. If it is not, we should keep in mind other reasons for the thrombocytopenia, such as drug use.
ISSN:2147-9720
2148-4279
DOI:10.5152/eurjrheum.2014.009